HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000074 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 4, 2026 |
| Document | View SEC Filing |
Transactions
15
Total Shares
150,000
Total Value
$4,577,008.22
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 1, 2026 | Sale | 1,610 | $66.39 | $106,884.68 | 786,170 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 1, 2026 | Sale | 12,989 | $67.41 | $875,588.49 | 773,181 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 1, 2026 | Sale | 5,401 | $68.35 | $369,136.75 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 2, 2026 | Sale | 16,600 | $66.31 | $1,100,812.40 | 771,180 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 2, 2026 | Sale | 3,400 | $66.75 | $226,933.00 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 3, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 777,780 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 3, 2026 | Sale | 400 | $66.37 | $26,547.20 | 777,380 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 3, 2026 | Sale | 1,500 | $67.67 | $101,512.50 | 775,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 3, 2026 | Sale | 2,000 | $68.74 | $137,472.00 | 773,880 | Direct | โ | View Details | |
Director | Common Stock | โ | Jun 3, 2026 | Sale | 6,100 | $69.69 | $425,121.20 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Jun 1, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 31,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Jun 2, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 11,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | Jun 3, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 1,923 | Direct | โ | View Details |